BDBM267922 4-{8-amino-3-[(2R)-4-(ethoxyacetyl)morpholin-2-yl]-5-methylimidazo[1,5-a]pyrazin-1-yl}-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide::US9718828, Example, 538

SMILES Cc1cnc(N)c2c(nc([C@H]3CN(CCO3)C(=O)C(F)F)n12)-c1ccc(cc1)C(=O)Nc1cc(ccn1)C(F)(F)F

InChI Key InChIKey=JTCBLJJIQQVPAA-QGZVFWFLSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 267922   

TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267922(4-{8-amino-3-[(2R)-4-(ethoxyacetyl)morpholin-2-yl]...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent